239 related articles for article (PubMed ID: 31751333)
1. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.
Mishra P; Colombe S; Paul N; Mlingi J; Tosiri I; Aristide C; Gao J; Kashangaki P; Nagai H; Kalluvya SE; de Dood CJ; Corstjens PL; Mngara J; van Dam GJ; Downs JA
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007844. PubMed ID: 31751333
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum-based real-time PCR to detect Schistosoma mansoni infection before and after treatment.
Fuss A; Mazigo HD; Mueller A
Infect Dis Poverty; 2020 Jun; 9(1):74. PubMed ID: 32571433
[TBL] [Abstract][Full Text] [Related]
5. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.
Tweyongyere R; Mawa PA; Emojong NO; Mpairwe H; Jones FM; Duong T; Dunne DW; Vennervald BJ; Katunguka-Rwakishaya E; Elliott AM
BMC Infect Dis; 2009 Mar; 9():32. PubMed ID: 19296834
[TBL] [Abstract][Full Text] [Related]
6. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
7. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.
Raso G; N'Goran EK; Toty A; Luginbühl A; Adjoua CA; Tian-Bi NT; Bogoch II; Vounatsou P; Tanner M; Utzinger J
Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):18-27. PubMed ID: 14702835
[TBL] [Abstract][Full Text] [Related]
12. Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood
Shen Y; Wiegand RE; Olsen A; King CH; Kittur N; Binder S; Zhang F; Whalen CC; Secor WE; Montgomery SP; Mwinzi PNM; Magnussen P; Kinung'hi S; Campbell CH; Colley DG
Am J Trop Med Hyg; 2019 Dec; 101(6):1336-1344. PubMed ID: 31407653
[TBL] [Abstract][Full Text] [Related]
13. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Faust CL; Crotti M; Moses A; Oguttu D; Wamboko A; Adriko M; Adekanle EK; Kabatereine N; Tukahebwa EM; Norton AJ; Gower CM; Webster JP; Lamberton PHL
Parasit Vectors; 2019 Dec; 12(1):607. PubMed ID: 31881923
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Impact of Different Mass Drug Administration Strategies on Infection with
Olsen A; Kinung'hi S; Magnussen P
Am J Trop Med Hyg; 2018 Dec; 99(6):1573-1579. PubMed ID: 30350779
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment.
Lamberton PH; Kabatereine NB; Oguttu DW; Fenwick A; Webster JP
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3139. PubMed ID: 25211217
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
[TBL] [Abstract][Full Text] [Related]
20. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
Black CL; Muok EM; Mwinzi PN; Carter JM; Karanja DM; Secor WE; Colley DG
J Infect Dis; 2010 Aug; 202(3):399-405. PubMed ID: 20560767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]